Traci Kyes and Makis Sigalas bring extensive industry experience to roles focused on expanding ViroCell’s business in the US and EuropeTeam ViroCell will be attending the Cell & Gene Therapy Meeting on the Mesa, 10-12 October 2023LONDON & NEW YORK (BUSINESS WIRE) ViroCell Biologics (“ViroCell” or the “Company”), a.
MALVERN, Pa., Oct. 04, 2023 Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today.
/PRNewswire/ ImmPACT Bio USA, Inc. ("ImmPACT BIO"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR).
BOSTON, October 02, 2023 Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that Abbey Jenkins, President and Chief Executive Officer, will present its corporate highlights at the annual Cell & Gene Meeting on the Mesa to be held October 10-12 in Carlsbad, California, and livestreamed globally. Ms. Jenkins will also participate in a panel titled "A record setting year for cell and gene therapies – how do we keep the momentum